Nanopath
Signal active
Organization
Contact Information
Overview
Nanopath Inc. is a molecular diagnostics company enabling high-quality molecular testing in minutes.
About
Industries
Biotechnology
Founded
2019
Employees
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Nanopath headquartered in United States, North America, operates in the Biotechnology sector. The company focuses on Biotechnology and has secured $171.1M in funding across 12 round(s). With a team of 11-50 employees, Nanopath is actively contributing to advancements in Biotechnology. Their latest funding round, Grant - Nanopath, raised $4.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
3
Investors
2
Lead Investors
0
Total Funding Amount
$14.3M
Details
1
Nanopath has raised a total of $14.3M in funding over 1 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2022 | Early Stage Venture | 10.0M |
Investors
Nanopath is funded by 16 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Apollo Projects | - | FUNDING ROUND - Apollo Projects | 255.9K |
| National Science Foundation | - | FUNDING ROUND - National Science Foundation | 4.0M |
| Nanopath | - | FUNDING ROUND - Nanopath | 4.0M |
| National Institutes of Health | - | FUNDING ROUND - National Institutes of Health | 4.0M |
Recent Activity
There is no recent news or activity for this profile.